KISSEI PHARMACEUTICAL CO.,LTD.

4547

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-07-31FY2027 Q1

Revenue

986100M JPY

YoY +10.3%

Operating Income

10.9100M JPY

YoY -48.1%

Net Income

139.8100M JPY

YoY +13.0%

EPS

114.0JPY

YoY +5.6%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

974.1億円

723.2億円

472.4億円

221.6億円

-29.3億円

Rev: 653.8億円Op: -14億円NI: 129.2億円

Rev: 674.9億円Op: -11.3億円NI: 105.3億円

Rev: 755.8億円Op: 40.2億円NI: 111.6億円

Rev: 883.3億円Op: 57.7億円NI: 119.6億円

Rev: 974.1億円Op: -29.3億円NI: 137.8億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income35.5%

Revenue Progress233.900M

Revenue Forecast88700M

Net Income Progress47.200M

Net Income Forecast13300M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan